Accolade Inc. (ACCD)
NASDAQ: ACCD
· Real-Time Price · USD
7.02
0.00 (0.00%)
At close: Apr 07, 2025, 3:59 PM
0.00% (1D)
| Bid | 7.01 |
| Market Cap | 575.59M |
| Revenue (ttm) | 446.72M |
| Net Income (ttm) | -180.3M |
| EPS (ttm) | -2.28 |
| PE Ratio (ttm) | -3.08 |
| Forward PE | n/a |
| Analyst | Hold |
| Ask | 7.03 |
| Volume | 4,543,947 |
| Avg. Volume (20D) | 1,565,611 |
| Open | 7.02 |
| Previous Close | 7.02 |
| Day's Range | 7.02 - 7.02 |
| 52-Week Range | 3.08 - 9.67 |
| Beta | 2.10 |
About ACCD
Accolade, Inc., together with its subsidiaries, develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and clinicians, including nurses, physician medical directors, and behavioral health specialists. It also prov...
Sector Healthcare
IPO Date Jul 1, 2020
Employees 2,400
Stock Exchange NASDAQ
Ticker Symbol ACCD
Website https://www.accolade.com
Analyst Forecast
According to 11 analyst ratings, the average rating for ACCD stock is "Hold." The 12-month stock price forecast is $6, which is a decrease of -14.53% from the latest price.
Stock ForecastsNext Earnings Release
Accolade Inc. is scheduled to release its earnings on May 6, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
3 months ago
+104.78%
Accolate shares are trading higher after the compa...
Unlock content with
Pro Subscription
6 months ago
+5.87%
Accolade shares are trading higher. Needham reiterated a Buy rating on the stock and maintained a price target of $8.
